Neuropathic pain

Handbook of Clinical Neurology

Volumn 110, Issue , 2013, Pages 175-187

  Kerstman, Eric ^a   Ahn, Sangmin ^a   Battu, Sree ^a   Tariq, Shabrez ^a   Grabois, Martin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872310717     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52901-5.00015-0     Document Type: Chapter

References (81)

1. Abramowicz M. Tramadol: a new oral analgesic. Med Lett Drugs Ther 1995, 37:59-62.
2. Alimi D., Rubino C., Pichard-Leandri E., et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003, 21:4120.
3. Alper B.S., Lewis P.R. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract 2002, 15:121.
4. Avellanosa A.M., West C.R. Experience with transcutaneous electrical nerve stimulation for relief of intractable pain in cancer patients. J Med 1982, 19:46.
5. Backonja M.M., Walk D., Edwards R.R., et al. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009, 25:641-647.
6. Baron R., Tolle T.R. Assessment and diagnosis of neuropathic pain. Curr Opin Support Palliat Care 2008, 2:1-8.
7. Bedder M.D. Spinal cord stimulation and intractable pain: patient selection. Interventional Pain Management 1996, 412. Dannemiller Memorial Educational Foundation, Philadelphia. S.D. Waldman, A. Winnie (Eds.).
8. Bennett M.I., Attal N., Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007, 127:199-203.
9. Breitbart W. Psychiatric management of cancer pain. Cancer 1989, 63:2336.
10. Burchiel K.J., Hsu F.P. Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine 2001, 26:S146.
11. Chaudhry V., Stevens J.C., Kincaid J., et al. Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2006, 66:1805-1808.
12. Chen H., Lamer T.J., Rho R.H., et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 2004, 79:1533-1545.
13. Cruccu G., Aziz T.Z., Garcia-Larrea L., et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007, 14:952-970.
14. Daousi C., Benbow S.J., MacFarlane I.A. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 2005, 22:393-398.
15. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
16. Dellon A.L. Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves. Plast Reconstr Surg 1992, 89:689.
17. Denkers M.R., Biagi H.L., Ann O'Brien M., et al. Dorsal root entry zone lesioning used to treat central neuropathic pain in patients with traumatic spinal cord injury: a systematic review. Spine 2009, 27:E177.
18. Devor M., Seltzer Z. Pathophysiology of damaged nerves in relation to chronic pain. Textbook of Pain 1999, 129-164. Churchill Livingstone, Edinburgh. P.D. Wall, R. Melzack (Eds.).
19. Dworkin R., Backonja M., Rowbotham M.C., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003, 60:1524-1527.
20. Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
21. Fava M., Mulroy R., Alpert J., et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry 1997, 154:1760-1762.
22. Feldman E.L., Stevens M.J., Greene D.A. Treatment of diabetic neuropathy. Advances in Endocrinology and Metabolism 1994, 393. Mosby Year Book, Chicago. E.L. Mazzaferri, R.S. Bar, R.A. Kreisbert (Eds.).
23. Finnerup N.B., Finnerup M., Otto T.S., et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
24. Fontaine D., Hamani C., Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: a critical review of the literature. J Neurosurg 2009, 110:251-256.
25. Galer B.S., Dworkin R.H. A Clinical Guide to Neuropathic Pain 2000, McGraw Hill, Minneapolis.
26. Gammaitoni A.R., Davis M.W. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002, 36:236-240.
27. Gilron I., Bailey J.M., Tu D., et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
28. Gilron I., Watson C.P., Cahill C.M., et al. Neuropathic pain: a practice guide for clinicians. Can Med Assoc J 2006, 175:265-275.
29. Gilron I., Bailey J.M., Tu D., et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial. Lancet 2009, 374:1252-1261.
30. Gronseth G., Cruccu G., Alksne J., et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008, 71:1183-1190.
31. Haanpaa M.L., Backonja M.M., Bennett M., et al. Assessment of neuropathic pain in primary care. Am J Med 2009, 122:S13-S21.
32. Haythornthwaite J.A., Benrud-Larson L.M. Psychological aspects of neuropathic pain. Clin J Pain 2000, 16:S101-S105.
33. Hempenstall K., Nurmikko T.J., Johnson R.W., et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005, 2:628-644.
34. Hogan Q.H., Abram S.E. Neural blockade for diagnosis and prognosis: a review. Anesthesiology 1997, 86:216-241.
35. Hsu E.S. Practical management of complex regional pain syndrome. Am J Ther 2009, 16:147-154.
36. Jensen T., Gottrup H. Assessment of neuropathic pain. Clinical Pain Management 2001, Arnold, London. D. Justins, A. Rice, E. Warfield (Eds.).
37. Jones M.J., Murrin K.R. Intercostal block with cryotherapy. Ann R Coll Surg Engl 1987, 69:261.
38. Katayama Y., Yamamoto T., Kobayashi K., et al. Motor cortex stimulation for post-stroke pain: comparison of spinal cord and thalamic stimulation. Stereotact Funct Neurosurg 2001, 77:183-186.
39. Khedr E.M., Kotb H., Jamel N.F., et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnet stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005, 76:833-838.
40. Kikuchi A., Kotani N., Sato T., et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999, 24:287-293.
41. Koltzenburg M., Scadding J. Neuropathic Pain: Bench to Bedside 2005, Royal Society of Medicine Press, London.
42. Kotani N., Kushikata T., Hashimoto H., et al. Intrathecal methylprednisolone for intracatable postherpetic neuralgia. N Engl J Med 2000, 343:1514-1519.
43. Krainick J.U., Thoden U., Reichert T. Pain reduction in amputees by long term spinal cord stimulation: long term follow up study over 5 years. J Neurosurg 1980, 52:346.
44. Kumar D., Marshall J.H. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 1997, 20:1702.
45. Kumar K., Malik S., Demeria D. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis. Neurosurgery 2002, 51:106-115.
46. Lanteri-Minet M., Bouhassira D., Attal N. STOPNEP: Study of Prevalence of Neuropathic Pain 2005.
47. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926.
48. Leung A., Donohue M., Xu R., et al. rTMS for suppressing neuropathic pain: a meta-analysis. J Pain 2009, 10:1205-1216.
49. Marsky H., Bogduk N. Classification of Chronic Pain 1994, IASP Press, Seattle.
50. McDermott A.M., Toelle T.R., Rowbotham D.J., et al. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006, 10:127-135.
51. McKinley W.O., Gittler M.S., Krishblum S.C., et al. Spinal cord injury medicine. 2. Medical complications after spinal cord injury: identification and management. Arch Phys Med Rehabil 2002, 83(Suppl 1):S58-S64. S90-S98.
52. North R.B., Kidd D.H., Zahurak M., et al. Spinal cord stimulation for chronic, intractable pain: experience over two decades. Neurosurgery 1993, 32:384-394.
53. O'Connor A.B. Neuropathic pain: a review of the quality of life impact, costs and cost-effectiveness of therapy. Pharmacoeconomics 2009, 27:95-112.
54. O'Connor A.B., Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122(Suppl): 2009, S22-S32.
55. Owen S.L., Green A.L., Stein J.F., et al. Deep brain stimulation for the alleviation of post-stroke neuropathic pain. Pain 2006, 120:202-206.
56. Oxford Centre for Evidence-Based Medicine 2009, http://www.cebm.net/index.aspx?o=1025.
57. Pappagallo M. Neuropathic pain in peripheral neuropathies. Practical Pain Management 2002, 431-448. Lippincott, Williams and Wilkins, Philadelphia. 3rd edn. C.D. Tollison, J.R. Satterthwoite, J.W. Tollison (Eds.).
58. Rainov N.G., Heidecke V., Burkert W. Long-term intrathecal infusion of drug combination for chronic back pain and leg pain. J Pain Symptom Manage 2001, 22:862-871.
59. Rauck R.L., Wallace M.S., Burton A.W., et al. Intrathecal ziconotide for neuropathic pain: a review. Pain Practice 2009, 9:327-333.
60. Ray W.A., Meredith S., Thapa P.B., et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004, 75:234-241.
61. Rhiner M., Ferrell B.R., Ferrell B.A., et al. A structured nondrug intervention program for cancer pain. Cancer Pract 1993, 1:137-143.
62. Richeimer S. Understanding Neuropathic Pain. The Richeimer Institute. 2000, (accessed 2 Feb 2010). http://www.spineuniverse.com/conditions/understanding-neuropathicpain.
63. Romanelli P., Esposito V., Adler J. Ablative procedures for chronic pain. Neurosurg Clin N Am 2004, 15:335-342.
64. Rowbotham M.C., Goli V., Kunz N.R., et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy. a double-blind, placebo-controlled study. Pain. Erratum 2005, 113:248-706.
65. Saarto T., Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005, 3:CD005454.
66. Sadosky A., McDermott A., Brandenberg N. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008, 8:45-56.
67. Seifert F., Maihofner C. Central mechanisms of experimental and chronic neuropathic pain: findings from functional imaging studies. Cell Mol Life Sci 2009, 66:375-390.
68. Siddall P.J., Cousins M.J., Otte A., et al. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006, 67:1792-1800.
69. Simpson E.L., Duenas A., Holmes M.W., et al. Spinal cord stimulation for chronic pain or neuropathic pain of ischaemic origin: systematic review and economic evaluation. Health Technol Assess 2009, 13. iii, ix-x.
70. Sindrup S.H., Bach F.W., Madsen C. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003, 60:1284-1289.
71. Sindrup S.H., Otto M., Finnerup N.B., et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005, 96:399-409.
72. Stanton-Hicks M., Baron R., Boas R., et al. Complex regional pain syndrome: guidelines for therapy. Clin J Pain 1998, 14:155-166.
73. Stephenson D.T., Arneric S.P. Neuroimaging of pain: advances and future prospects. J Pain 2008, 9:567-579.
74. Svendsen K.B., Jensen T.S., Bach F.W. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004, 329:253.
75. Taylor R.S. Epidemiology of refractory neuropathic pain. Pain Pract 2006, 6:22-26.
76. Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care 2009, 3:136-143.
77. Tesfaye S., Watt J, Benbow S.J., et al. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996, 348:1696-1701.
78. Vinik E.J., Hayes R.P., Oglesby A., et al. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetes neuropathy. Diabetes Technol Ther 2005, 7:497-508.
79. Wagner R., Myers R.R. Mechanisms and management of neuropathic pain. Atlas of Anesthesia, Pain Management 1998, vol. 50. Chap 3., Philadelphia. S.E. Aban (Ed.).
80. Withrington R.H., Wynn Parry C.B. The management of painful peripheral nerve disorder. J Hand Surg 1984, 9:24-28.
81. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.